Samples of maternal blood, amniotic fluid and umbilical arterial and venous blood were collected from 11 women at 16\p=n-\24 weeks of pregnancy. Corticotrophin\x=req-\ releasing hormone-41 (CRH-41) and ACTH were measured by immunoradiometric assay. The mean levels of ACTH were 11 pmol/l in maternal plasma, 12 pmol/l in fetal plasma and 9\ m=. \ 7 pmol/l in amniotic fluid. The mean levels of CRH-41 were 1\ m=. \ 6 pmol/l in maternal plasma and 0\ m=. \ 7 pmol/l in fetal plasma. There was a positive correlation between maternal and fetal plasma CRH-41 and between maternal CRH-41 and ACTH. In fetal plasma there was a weak inverse correlation between CRH-41 and ACTH. This is the first demonstration of CRH-41 in the circulation of the mid-trimester human fetus, but on the basis of the present findings it is not possible to specify the exact source (fetal, placental or maternal).
INTRODUCTION
Until very recently, studies of human fetal endocrin¬ ology have relied on the use of abortion or hysterec¬ tomy specimens. However, it is now possible to gain direct access to the intact fetal circulation in utero by fetoscopy (Rodeck & Campbell, 1978 ; Nicolaides & Rodeck, 1984) and, even more recently, by cordocentesis (Daffos, Cappela-Pavlosky & Forestier, 1983; Nicolaides, Soothill, Rodeck & Campbell, 1986) .
Current information on adrenocorticotrophin (ACTH) and corticotrophin-releasing hormone-41 (CRH-41) in maternal and fetal blood and the placenta is summarized in (Nicolaides & Rodeck, 1984) -3/5
ÖS ÖS ft.
• Mean (± s.d.) 9-7(3-3) 1-6(0-9) 11-5(5-7) 0-7(0-5) 11-9(2-7)
*Plasma concentrations of CRH-41 and ACTH were below the quoted level of detection of their respective assays and have therefore been assigned a value equal to the limit of detection of each assay.
Assay of CRH-41
Plasma concentrations of CRH-41 were measured directly using a specific two-site immunoradiometric assay (IRMA) without an extraction step. The methodology was as described by Linton, McLean, Kruseman et al. (1987) . Assay sensitivity was 0-2 pmol/1, allowing the measurement of basal levels of CRH-41 in normal subjects of 3-1 ± 1-5 (s.d.) pmol/1 (range 0-4-5-9 pmol/1). The intra-and interassay coefficients of variation for a normal plasma pool con¬ taining 2-7pmolCRH-41/1 were2-7and60% respect¬ ively (« = ten samples in eight assays). Assay of ACTH Plasma concentrations of ACTH were measured directly by IRMA as described previously (Hodgkinson, Allolio, Landon & Lowry, 1984) . Assay sensitivity was 1-8 pmol ACTH/1 (95% confidence interval 0-4-2-3 pmol/1). A range of 5-5-14 pmol/1 was obtained for plasma samples collected between 09.00 and 11.00 h from 25 normal volunteers.
The relationship between parameters was evaluated by simple linear regression analysis.
RESULTS
The levels of ACTH and CRH-41 in the fluids exam¬ ined are summarized in Table 2 . The mean levels of ACTH in maternal and fetal blood were very similar (11-5 + 5-7 (s.d.) and 11-9 ±2-7 pmol/1 respectively).
The maternal plasma concentration of CRH-41 was rather higher than that in the fetus (1-6 + 0-9 and 0-7 + 0-5 pmol/1 respectively). Maternal (Kauppila, Tuimala & Haapalahti, 1976) . The amniotic concentrations of ACTH recorded here were also much lower than those described in earlier studies (average 24 pmol/1 at 10-18 weeks of gestation) (Kauppila et al. 1976 ). Blumenfield & Jaffe, 1986; Wintour, Bell, Carson et al. 1986 ) and this response is inhibited by cortisol (Rose et al. 1985) . The negative correlation between fetal CRH-41 and ACTH, though paradoxical, is relatively weak and should not be overinterpreted until it is confirmed or disproved by further studies.
